Cytek Biosciences Set to Join S&P SmallCap 600
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes
Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Cardiovascular Systems, Inc. - CSII
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII
Abbott Buying Cardiovascular Systems: Details (ABT)
Cardiovascular Systems (CSII) Q2 Earnings, Revenues Miss
SHAREHOLDER ALERT: Weiss Law Investigates Cardiovascular Systems, Inc.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Cardiovascular Systems, Inc. Buyout
Why Cardiovascular Systems Stock Is Soaring Today
Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?
CSII STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Cardiovascular Systems, Inc. Is Fair to Shareholders
CSII STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Cardiovascular Systems, Inc. Is Fair to Shareholders
Cardiovascular Systems shares jump after deal to be bought by Abbott for $890 million
Cardiovascular Systems (CSII) Reports Q2 Loss, Misses Revenue Estimates
Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results
Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results
Cardiovascular Systems (CSII) Global Sales Up, Margin Woe Stays
Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023
Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023
Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study
Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.'s Thrombectomy System
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
Cardiovascular Systems (CSII) Q1 Earnings Miss, Revenues Top
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
Cardiovascular Systems, Inc. (CSII) Q1 2023 Earnings Call Transcript
Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
Why Is Cardiovascular Systems (CSII) Down 18.9% Since Last Earnings Report?
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
A Debt-Free and Fairly Valued Medical Devices Company
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2022 Results - Earnings Call Transcript
Cardiovascular Systems' (CSII) Q3 Earnings Top Estimates